Stephen Strakowski Appointed UC Chair of Psychiatry
The appointment is effective Nov. 1, pending approval by the UC Board of Trustees.
Strakowski has served as interim chair of the department since May 1, 2006. He has been a professor of psychiatry since 2000, with secondary appointments as professor of biomedical engineering and psychology. He is also a member of the neuroscience graduate program faculty.
Dr. Strakowski has been a valuable member of the college for 15 years, and has done a tremendous job of leading the psychiatry department as interim chair, said David Stern, MD, dean of the
A graduate of Vanderbilt University School of Medicine, Strakowski completed his residency training at McLean Hospital/Harvard University School of Medicine.
In addition to his academic responsibilities, he serves as attending clinical chief of psychiatry at
Strakowski has served in numerous leadership positions for the department and college and in the psychiatric profession. An experienced researcher, Strakowski also serves as director of the Center for Imaging Research, a core facility for the
He has served on several NIMH and VA federal grant review subcommittees and is a reviewer for most of the major psychiatric journals. He has received a number of awards, most notably the Gerald L. Klerman Award from the National Depressive and Manic-Depressive Association (NDMDA). He has been named among the Best Doctors in
Psychiatry and behavioral neuroscience professor and chair Stephen Strakowski, MD
Related Stories
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Phase 1 trial tests probiotic treatment for radiation side effects in the gut
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.